510(k) device
Vaginal Tactile Ultrasound Imager
Advanced Tactile Imaging, Inc. · Perineometer (HIR, Class II) · First FDA decision Feb 22, 2024, newest Feb 22, 2024Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
23
Naming "Vaginal Tactile"
MAUDE reports
0
Brand "Vaginal Tactile", since 2015
PubMed studies
25
Mentioning "Vaginal Tactile"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vaginal Tactile Ultrasound Imager
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K231875 · Decided Feb 22, 2024 · 241 days after receipt
Device type: Perineometer (HIR) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Vaginal Tactile", any status and sponsor, newest update first.
Liaquat University of Medical & Health SciencesAcademic, hospital or other
NCT06978907 · 75 participants · Start Jul 1, 2025 · Primary completion Nov 27, 2025
Device: Monnalisa Touch® Laser Therapy · For: Atrophic Vulvovaginitis
Sites: Roma, Italy; San Mariano, Italy
- Genitourinary Syndrome of Menopause in Breast CancerPivotal-lookingRecruiting
University of AlcalaAcademic, hospital or other
NCT06721936 · 182 participants (planned) · Start Nov 29, 2024 · Primary completion Dec 31, 2027
Device: Laser CO2 Therapy group · For: Genitourinary Syndrome of Menopause (GSM); Breast Cancer Female
Sites: Madrid, Spain
University Health Network, TorontoAcademic, hospital or other
NCT06568211 · 60 participants (planned) · Start Nov 17, 2022 · Primary completion Apr 2025
Device: Virtual Reality; Tablet-Only · For: Dementia
Sites: Toronto, Canada
20 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vaginal Tactile", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HIR
2 reports: 1 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vaginal Tactile"[tiab]. The summary above synthesizes these.
- Vaginal tactile imaging.
Egorov V, van Raalte H, Sarvazyan AP · IEEE Trans Biomed Eng · 2010
- Vaginal tactile imaging: A review.
Sarvazyan N, Francy B, Egorov V · Pelviperineology · 2023
- Characterizing female pelvic floor conditions by tactile imaging.
van Raalte H, Egorov V · Int Urogynecol J · 2015Observational Study, Research Support, N.I.H., Extramural
- Biomechanical Integrity Score of the Female Pelvic Floor for Stress Urinary Incontinence.
Takacs P, Rátonyi D, Koroknai E, et al. · Int Urogynecol J · 2024Observational Study, Validation Study
- Predictive Value of Biomechanical Mapping for Pelvic Organ Prolapse Surgery.
Egorov V, Takacs P, Shobeiri SA, et al. · Female Pelvic Med Reconstr Surg · 2021Multicenter Study, Research Support, N.I.H., Extramural
- Biomechanical integrity score of the female pelvic floor.
Egorov V, van Raalte H, Takacs P, et al. · Int Urogynecol J · 2022Multicenter Study, Observational Study
- Analysis of the anatomical and biomechanical characteristics of the pelvic floor in cystocele.
Song C, Wen W, Pan L, et al. · Acta Obstet Gynecol Scand · 2023Observational Study
- Tactile Imaging Markers to Characterize Female Pelvic Floor Conditions.
van Raalte H, Egorov V · Open J Obstet Gynecol · 2015
- The impact of short-term pelvic floor muscle training on the biomechanical parameters of the pelvic floor among patients with stress urinary incontinence: A pilot study.
Rátonyi D, Koroknai E, Pákozdy K, et al. · Eur J Obstet Gynecol Reprod Biol · 2024
- Tactile and Ultrasound Image Fusion for Functional Assessment of the Female Pelvic Floor.
Egorov V, van Raalte H, Shobeiri SA · Open J Obstet Gynecol · 2021
- Biomechanical paradigm and interpretation of female pelvic floor conditions before a treatment.
Lucente V, van Raalte H, Murphy M, et al. · Int J Womens Health · 2017
- Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.
Egorov V, Lucente V, Shobeiri SA, et al. · EC Gynaecol · 2018
Other devices of this type
Also filed under product code HIR.
- Flyte Mechanotherapy System, MTI-1.5 (MTI-1.5)Pelvital USA, Inc. · 510(k) 2024
- leva Pelvic Health SystemRenovia, Inc. · 510(k) 2022
- FlytePelvital USA, Inc. · 510(k) 2021
- Pelvic Floor Exerciser (PF01)Hunan Accurate Bio-Medical Technology Co., Ltd. · 510(k) 2026
- Perifit Care+X6 Innovations · 510(k) 2023
- PerifitX6 Innovations · 510(k) 2023
- Intimate Rose Kegel Exercise SystemPlus EV Holdings Dba Intimate Rose · 510(k) 2020
- Pelvital SystemPelvital USA, Inc. · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.